Inflammasomes and Pyroptosis of Liver Cells in Liver Fibrosis

Broz, 2016, Inflammasomes: Mechanism of Assembly, Regulation and Signalling, Nat Rev Immunol, 16, 10.1038/nri.2016.58

Christgen, 2020, Toward Targeting Inflammasomes: Insights Into Their Regulation and Activation, Cell Res, 30, 10.1038/s41422-020-0295-8

Zeng, 2021, Circular Rna as an Epigenetic Regulator in Chronic Liver Diseases, Cells, 10, 10.3390/cells10081945

Cai, 2021, Mechanism and Therapeutic Opportunities of Histone Modifications in Chronic Liver Disease, Front Pharmacol, 12, 10.3389/fphar.2021.784591

Kisseleva, 2021, Molecular and Cellular Mechanisms of Liver Fibrosis and Its Regression, Nat Rev Gastroenterol Hepatol, 18, 10.1038/s41575-020-00372-7

Koyama, 2017, Liver Inflammation and Fibrosis, J Clin Invest, 127, 55, 10.1172/jci88881

Tsuchida, 2017, Mechanisms of Hepatic Stellate Cell Activation, Nat Rev Gastroenterol Hepatol, 14, 397, 10.1038/nrgastro.2017.38

Cao, 2021, Regulation and Functional Roles of Chemokines in Liver Diseases, Nat Rev Gastroenterol Hepatol, 18, 10.1038/s41575-021-00444-2

Vanaja, 2015, Mechanisms of Inflammasome Activation: Recent Advances and Novel Insights, Trends Cell Biol, 25, 10.1016/j.tcb.2014.12.009

Martínez-Cardona, 2018, Aim2 Deficiency Reduces the Development of Hepatocellular Carcinoma in Mice, Int J Cancer, 143, 2997, 10.1002/ijc.31827

Faustin, 2007, Reconstituted Nalp1 Inflammasome Reveals Two-Step Mechanism of Caspase-1 Activation, Mol Cell, 25, 10.1016/j.molcel.2007.01.032

Finger, 2012, Autolytic Proteolysis Within the Function to Find Domain (Fiind) Is Required for Nlrp1 Inflammasome Activity, J Biol Chem, 287, 10.1074/jbc.M112.378323

Moayeri, 2012, Anthrax and the Inflammasome, Microbes Infect, 14, 392, 10.1016/j.micinf.2011.12.005

Pelegrin, 2006, Pannexin-1 Mediates Large Pore Formation and Interleukin-1beta Release by the Atp-Gated P2x7 Receptor, EMBO J, 25, 10.1038/sj.emboj.7601378

Wickliffe, 2008, Anthrax Lethal Toxin-Induced Inflammasome Formation and Caspase-1 Activation Are Late Events Dependent on Ion Fluxes and the Proteasome, Cell Microbiol, 10, 10.1111/j.1462-5822.2007.01044.x

Latz, 2013, Activation and Regulation of the Inflammasomes, Nat Rev Immunol, 13, 397, 10.1038/nri3452

Duncan, 2009, Neisseria Gonorrhoeae Activates the Proteinase Cathepsin B to Mediate the Signaling Activities of the Nlrp3 and Asc-Containing Inflammasome, J Immunol, 182, 10.4049/jimmunol.0802696

Mariathasan, 2006, Cryopyrin Activates the Inflammasome in Response to Toxins and Atp, Nature, 440, 10.1038/nature04515

Martinon, 2006, Gout-Associated Uric Acid Crystals Activate the Nalp3 Inflammasome, Nature, 440, 10.1038/nature04516

Halle, 2008, The Nalp3 Inflammasome Is Involved in the Innate Immune Response to Amyloid-Beta, Nat Immunol, 9, 10.1038/ni.1636

Woolbright, 2017, Role of the Inflammasome in Acetaminophen-Induced Liver Injury and Acute Liver Failure, J Hepatol, 66, 10.1016/j.jhep.2016.11.017

Szabo, 2012, Inflammasomes in Liver Diseases, J Hepatol, 57, 10.1016/j.jhep.2012.03.035

Miao, 2006, Cytoplasmic Flagellin Activates Caspase-1 and Secretion of Interleukin 1beta Via Ipaf, Nat Immunol, 7, 10.1038/ni1344

Mariathasan, 2004, Differential Activation of the Inflammasome by Caspase-1 Adaptors Asc and Ipaf, Nature, 430, 10.1038/nature02664

Miao, 2010, Innate Immune Detection of the Type Iii Secretion Apparatus Through the Nlrc4 Inflammasome, Proc Natl Acad Sci U S A, 107, 10.1073/pnas.0913087107

Tenthorey, 2014, Molecular Basis for Specific Recognition of Bacterial Ligands by Naip/Nlrc4 Inflammasomes, Mol Cell, 54, 17, 10.1016/j.molcel.2014.02.018

Etienne-Mesmin, 2016, Hepatocyte Toll-Like Receptor 5 Promotes Bacterial Clearance and Protects Mice Against High-Fat Diet-Induced Liver Disease, Cell Mol Gastroenterol Hepatol, 2, 584, 10.1016/j.jcmgh.2016.04.007

Chen, 2019, Nlrc4 Inflammasome Activation Regulated by Tnf-α Promotes Inflammatory Responses in Nonalcoholic Fatty Liver Disease, Biochem Biophys Res Commun, 511, 10.1016/j.bbrc.2019.02.099

Rathinam, 2010, The Aim2 Inflammasome Is Essential for Host Defense Against Cytosolic Bacteria and DNA Viruses, Nat Immunol, 11, 395, 10.1038/ni.1864

Hornung, 2009, Aim2 Recognizes Cytosolic Dsdna and Forms a Caspase-1-Activating Inflammasome With Asc, Nature, 458, 10.1038/nature07725

Mambwe, 2019, Tyrosine Dephosphorylation of Asc Modulates the Activation of the Nlrp3 and Aim2 Inflammasomes, Front Immunol, 10, 10.3389/fimmu.2019.01556

Xu, 2021, Mitochondrial DNA Enables Aim2 Inflammasome Activation and Hepatocyte Pyroptosis in Nonalcoholic Fatty Liver Disease, Am J Physiol Gastrointest Liver Physiol, 320, 10.1152/ajpgi.00431.2020

Sun, 2017, Redox-Dependent Regulation of Hepatocyte Absent in Melanoma 2 Inflammasome Activation in Sterile Liver Injury in Mice, Hepatology, 65, 10.1002/hep.28893

Lozano-Ruiz, 2015, Absent in Melanoma 2 Triggers a Heightened Inflammasome Response in Ascitic Fluid Macrophages of Patients With Cirrhosis, J Hepatol, 62, 64, 10.1016/j.jhep.2014.08.027

Wang, 2021, Perfluoroalkyl Substance Pollutants Activate the Innate Immune System Through the Aim2 Inflammasome, Nat Commun, 12, 2915, 10.1038/s41467-021-23201-0

Schnappauf, 2019, The Pyrin Inflammasome in Health and Disease, Front Immunol, 10, 10.3389/fimmu.2019.01745

Heilig, 2018, Function and Mechanism of the Pyrin Inflammasome, Eur J Immunol, 48, 10.1002/eji.201746947

Mulvihill, 2018, Mechanism of Membrane Pore Formation by Human Gasdermin-D, EMBO J, 37, 10.15252/embj.201798321

Rathinam, 2016, Inflammasome Complexes: Emerging Mechanisms and Effector Functions, Cell, 165, 792, 10.1016/j.cell.2016.03.046

He, 2015, Gasdermin D Is an Executor of Pyroptosis and Required for Interleukin-1β Secretion, Cell Res, 25, 10.1038/cr.2015.139

Shi, 2015, Cleavage of Gsdmd by Inflammatory Caspases Determines Pyroptotic Cell Death, Nature, 526, 10.1038/nature15514

Kist, 2021, Cell Death Pathways: Intricate Connections and Disease Implications, EMBO J, 40, 10.15252/embj.2020106700

Kayagaki, 2015, Caspase-11 Cleaves Gasdermin D for Non-Canonical Inflammasome Signalling, Nature, 526, 10.1038/nature15541

Bauernfeind, 2009, Cutting Edge: Nf-Kappab Activating Pattern Recognition and Cytokine Receptors License Nlrp3 Inflammasome Activation by Regulating Nlrp3 Expression, J Immunol, 183, 10.4049/jimmunol.0901363

Zhou, 2011, A Role for Mitochondria in Nlrp3 Inflammasome Activation, Nature, 469, 10.1038/nature09663

Rühl, 2015, Caspase-11 Activates a Canonical Nlrp3 Inflammasome by Promoting K(+) Efflux, Eur J Immunol, 45, 10.1002/eji.201545772

Parola, 2019, Liver Fibrosis: Pathophysiology, Pathogenetic Targets and Clinical Issues, Mol Aspects Med, 65, 37, 10.1016/j.mam.2018.09.002

Marrone, 2016, Sinusoidal Communication in Liver Fibrosis and Regeneration, J Hepatol, 65, 10.1016/j.jhep.2016.04.018

Gao, 2021, Endothelial P300 Promotes Portal Hypertension and Hepatic Fibrosis Through C-C Motif Chemokine Ligand 2-Mediated Angiocrine Signaling, Hepatology, 73, 10.1002/hep.31617

Gao, 2020, Hepatic Stellate Cell Autophagy Inhibits Extracellular Vesicle Release to Attenuate Liver Fibrosis, J Hepatol, 73, 10.1016/j.jhep.2020.04.044

Strowig, 2012, Inflammasomes in Health and Disease, Nature, 481, 10.1038/nature10759

Szabo, 2015, Inflammasome Activation and Function in Liver Disease, Nat Rev Gastroenterol Hepatol, 12, 387, 10.1038/nrgastro.2015.94

Schuster-Gaul, 2020, Ask1 Inhibition Reduces Cell Death and Hepatic Fibrosis in an Nlrp3 Mutant Liver Injury Model, JCI Insight, 5, 10.1172/jci.insight.123294

Luan, 2018, Inflammasome: A Double-Edged Sword in Liver Diseases, Front Immunol, 9, 10.3389/fimmu.2018.02201

Wree, 2014, Nlrp3 Inflammasome Activation Results in Hepatocyte Pyroptosis, Liver Inflammation, and Fibrosis in Mice, Hepatology, 59, 898, 10.1002/hep.26592

Zhang, 2015, Reactive Oxygen Species-Induced Txnip Drives Fructose-Mediated Hepatic Inflammation and Lipid Accumulation Through Nlrp3 Inflammasome Activation, Antioxid Redox Signal, 22, 10.1089/ars.2014.5868

Wan, 2016, Uric Acid Regulates Hepatic Steatosis and Insulin Resistance Through the Nlrp3 Inflammasome-Dependent Mechanism, J Hepatol, 64, 10.1016/j.jhep.2015.11.022

Zhang, 2019, Impaired Mitophagy Triggers Nlrp3 Inflammasome Activation During the Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis, Lab Invest, 99, 10.1038/s41374-018-0177-6

Yu, 2019, Liraglutide Ameliorates Non-Alcoholic Steatohepatitis by Inhibiting Nlrp3 Inflammasome and Pyroptosis Activation Via Mitophagy, Eur J Pharmacol, 864, 10.1016/j.ejphar.2019.172715

Zhu, 2021, Caspase-11-Mediated Hepatocytic Pyroptosis Promotes the Progression of Nonalcoholic Steatohepatitis, Cell Mol Gastroenterol Hepatol, 12, 10.1016/j.jcmgh.2021.04.009

Gaul, 2021, Hepatocyte Pyroptosis and Release of Inflammasome Particles Induce Stellate Cell Activation and Liver Fibrosis, J Hepatol, 74, 10.1016/j.jhep.2020.07.041

Heo, 2019, Alcohol Dysregulates Mir-148a in Hepatocytes Through Foxo1, Facilitating Pyroptosis Via Txnip Overexpression, Gut, 68, 10.1136/gutjnl-2017-315123

Khanova, 2018, Pyroptosis by Caspase11/4-Gasdermin-D Pathway in Alcoholic Hepatitis in Mice and Patients, Hepatology, 67, 10.1002/hep.29645

Frissen, 2021, Bidirectional Role of Nlrp3 During Acute and Chronic Cholestatic Liver Injury, Hepatology, 73, 10.1002/hep.31494

Lebeaupin, 2018, Bax Inhibitor-1 Protects From Nonalcoholic Steatohepatitis by Limiting Inositol-Requiring Enzyme 1 Alpha Signaling in Mice, Hepatology, 68, 10.1002/hep.29847

Lebeaupin, 2015, Er Stress Induces Nlrp3 Inflammasome Activation and Hepatocyte Death, Cell Death Dis, 6, e1879, 10.1038/cddis.2015.248

Han, 2018, Fxr Inhibits Endoplasmic Reticulum Stress-Induced Nlrp3 Inflammasome in Hepatocytes and Ameliorates Liver Injury, Cell Rep, 24, 10.1016/j.celrep.2018.07.068

Koh, 2021, Sphingomyelin Synthase 1 Mediates Hepatocyte Pyroptosis to Trigger Non-Alcoholic Steatohepatitis, Gut, 70, 10.1136/gutjnl-2020-322509

Kazankov, 2019, The Role of Macrophages in Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis, Nat Rev Gastroenterol Hepatol, 16, 10.1038/s41575-018-0082-x

Tacke, 2017, Targeting Hepatic Macrophages to Treat Liver Diseases, J Hepatol, 66, 10.1016/j.jhep.2017.02.026

Wang, 2017, The Tir/Bb-Loop Mimetic as-1 Prevents Non-Alcoholic Steatohepatitis and Hepatic Insulin Resistance by Inhibiting Nlrp3-Asc Inflammasome Activation, Br J Pharmacol, 174, 10.1111/bph.13786

Wang, 2021, Ginseng Saponin Enriched in Rh1 and Rg2 Ameliorates Nonalcoholic Fatty Liver Disease by Inhibiting Inflammasome Activation, Nutrients, 13, 10.3390/nu13030856

Mohammed, 2021, Role of Necroptosis in Chronic Hepatic Inflammation and Fibrosis in a Mouse Model of Increased Oxidative Stress, Free Radic Biol Med, 164, 10.1016/j.freeradbiomed.2020.12.449

Wang, 2021, Myeloid Nrf2 Deficiency Aggravates Non-Alcoholic Steatohepatitis Progression by Regulating Yap-Mediated Nlrp3 Inflammasome Signaling, iScience, 24, 10.1016/j.isci.2021.102427

Tao, 2021, Rip1 Kinase Activity Promotes Steatohepatitis Through Mediating Cell Death and Inflammation in Macrophages, Cell Death Differ, 28, 10.1038/s41418-020-00668-w

Shi, 2020, Tgr5 Regulates Macrophage Inflammation in Nonalcoholic Steatohepatitis by Modulating Nlrp3 Inflammasome Activation, Front Immunol, 11, 10.3389/fimmu.2020.609060

Miura, 2013, Toll-Like Receptor 2 and Palmitic Acid Cooperatively Contribute to the Development of Nonalcoholic Steatohepatitis Through Inflammasome Activation in Mice, Hepatology, 57, 10.1002/hep.26081

Shen, 2017, Dietary Pufas Attenuate Nlrp3 Inflammasome Activation Via Enhancing Macrophage Autophagy, J Lipid Res, 58, 10.1194/jlr.M075879

Liu, 2019, Tim-4 Inhibits Nlrp3 Inflammasome Via the Lkb1/Ampkα Pathway in Macrophages, J Immunol, 203, 990, 10.4049/jimmunol.1900117

Kim, 2017, Ezetimibe Ameliorates Steatohepatitis Via Amp Activated Protein Kinase-Tfeb-Mediated Activation of Autophagy and Nlrp3 Inflammasome Inhibition, Autophagy, 13, 10.1080/15548627.2017.1356977

Ioannou, 2015, Cholesterol-Lowering Drugs Cause Dissolution of Cholesterol Crystals and Disperse Kupffer Cell Crown-Like Structures During Resolution of Nash, J Lipid Res, 56, 10.1194/jlr.M053785

Antonopoulos, 2015, Caspase-8 as an Effector and Regulator of Nlrp3 Inflammasome Signaling, J Biol Chem, 290, 10.1074/jbc.M115.652321

Zhang, 2014, Flavonoid Apigenin Inhibits Lipopolysaccharide-Induced Inflammatory Response Through Multiple Mechanisms in Macrophages, PloS One, 9, 10.1371/journal.pone.0107072

Hua, 2015, Cyclooxygenase-2 Regulates Nlrp3 Inflammasome-Derived Il-1β Production, J Cell Physiol, 230, 10.1002/jcp.24815

Gao, 2016, Celecoxib and Octreotide Synergistically Ameliorate Portal Hypertension Via Inhibition of Angiogenesis in Cirrhotic Rats, Angiogenesis, 19, 10.1007/s10456-016-9522-9

Tai, 2021, Celecoxib Reduces Hepatic Vascular Resistance in Portal Hypertension by Amelioration of Endothelial Oxidative Stress, J Cell Mol Med, 25, 10.1111/jcmm.16968

Tang, 2021, Celecoxib Ameliorates Liver Cirrhosis Via Reducing Inflammation and Oxidative Stress Along Spleen-Liver Axis in Rats, Life Sci, 272, 10.1016/j.lfs.2021.119203

Su, 2020, Celecoxib Attenuates Hepatocyte Apoptosis by Inhibiting Endoplasmic Reticulum Stress in Thioacetamide-Induced Cirrhotic Rats, World J Gastroenterol, 26, 10.3748/wjg.v26.i28.4094

Shang, 2018, Leucodin Attenuates Inflammatory Response in Macrophages and Lipid Accumulation in Steatotic Hepatocytes Via P2x7 Receptor Pathway: A Potential Role in Alcoholic Liver Disease, BioMed Pharmacother, 107, 10.1016/j.biopha.2018.08.009

Petrasek, 2015, Metabolic Danger Signals, Uric Acid and Atp, Mediate Inflammatory Cross-Talk Between Hepatocytes and Immune Cells in Alcoholic Liver Disease, J Leukoc Biol, 98, 10.1189/jlb.3AB1214-590R

Mathews, 2013, Therapeutic Potential of Interleukin 1 Inhibitors in the Treatment of Alcoholic Liver Disease, Hepatology, 57, 10.1002/hep.26336

Kim, 2018, Spliceosome-Associated Protein 130 Exacerbates Alcohol-Induced Liver Injury by Inducing Nlrp3 Inflammasome-Mediated Il-1β in Mice, Am J Pathol, 188, 10.1016/j.ajpath.2017.12.010

Orecchioni, 2019, Macrophage Polarization: Different Gene Signatures in M1(Lps+) Vs. Classically and M2(Lps-) Vs. Alternatively Activated Macrophages, Front Immunol, 10, 10.3389/fimmu.2019.01084

Ilyas, 2019, Decreased Macrophage Autophagy Promotes Liver Injury and Inflammation From Alcohol, Alcohol Clin Exp Res, 43, 10.1111/acer.14041

Negash, 2013, Il-1β Production Through the Nlrp3 Inflammasome by Hepatic Macrophages Links Hepatitis C Virus Infection With Liver Inflammation and Disease, PloS Pathog, 9, 10.1371/journal.ppat.1003330

Serti, 2014, Monocytes Activate Natural Killer Cells Via Inflammasome-Induced Interleukin 18 in Response to Hepatitis C Virus Replication, Gastroenterology, 147, 209, 10.1053/j.gastro.2014.03.046

Negash, 2019, Modulation of Calcium Signaling Pathway by Hepatitis C Virus Core Protein Stimulates Nlrp3 Inflammasome Activation, PloS Pathog, 15, 10.1371/journal.ppat.1007593

Zhang, 2019, Nlrp3 Inflammasome Activation From Kupffer Cells Is Involved in Liver Fibrosis of Schistosoma Japonicum-Infected Mice Via Nf-κb, Parasit Vectors, 12, 29, 10.1186/s13071-018-3223-8

Wang, 2021, Psoralidin, a Major Component of Psoraleae Fructus, Induces Inflammasome Activation and Idiosyncratic Liver Injury, Int Immunopharmacol, 92, 10.1016/j.intimp.2020.107352

Jia, 2020, Nlrp3 Inflammasome and Related Cytokines Reflect the Immune Status of Patients With Hbv-Aclf, Mol Immunol, 120, 10.1016/j.molimm.2020.01.011

Zannetti, 2016, Characterization of the Inflammasome in Human Kupffer Cells in Response to Synthetic Agonists and Pathogens, J Immunol, 197, 10.4049/jimmunol.1502301

Sanches, 2020, Nlrp6 Plays an Important Role in Early Hepatic Immunopathology Caused by Schistosoma Mansoni Infection, Front Immunol, 11, 10.3389/fimmu.2020.00795

Silveira, 2017, Nlrp12 Negatively Regulates Proinflammatory Cytokine Production and Host Defense Against Brucella Abortus, Eur J Immunol, 47, 10.1002/eji.201646502

Lazaridis, 2015, The Cholangiopathies, Mayo Clin Proc, 90, 791, 10.1016/j.mayocp.2015.03.017

Maroni, 2017, Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes, Am J Pathol, 187, 10.1016/j.ajpath.2016.10.010

Fabris, 2019, Pathobiology of Inherited Biliary Diseases: A Roadmap to Understand Acquired Liver Diseases, Nat Rev Gastroenterol Hepatol, 16, 497, 10.1038/s41575-019-0156-4

Lan, 2022, Role of Immune Cells in Biliary Repair, Front Immunol, 13, 10.3389/fimmu.2022.866040

Tian, 2016, Galectin-3 Regulates Inflammasome Activation in Cholestatic Liver Injury, FASEB J, 30, 10.1096/fj.201600392RR

Watanabe, 2009, Inflammasome-Mediated Regulation of Hepatic Stellate Cells, Am J Physiol Gastrointest Liver Physiol, 296, 10.1152/ajpgi.90223.2008

Dong, 2020, Palmitic Acid Stimulates Nlrp3 Inflammasome Activation Through Tlr4-Nf-κb Signal Pathway in Hepatic Stellate Cells, Ann Transl Med, 8, 168, 10.21037/atm.2020.02.21

Duan, 2017, Palmitic Acid Elicits Hepatic Stellate Cell Activation Through Inflammasomes and Hedgehog Signaling, Life Sci, 176, 42, 10.1016/j.lfs.2017.03.012

Wu, 2015, Tetramethylpyrazine Reduces Inflammation in Liver Fibrosis and Inhibits Inflammatory Cytokine Expression in Hepatic Stellate Cells by Modulating Nlrp3 Inflammasome Pathway, IUBMB Life, 67, 10.1002/iub.1348

Zhao, 2019, P66shc Contributes to Liver Fibrosis Through the Regulation of Mitochondrial Reactive Oxygen Species, Theranostics, 9, 10.7150/thno.29620

Ning, 2017, Microrna-21 Mediates Angiotensin Ii-Induced Liver Fibrosis by Activating Nlrp3 Inflammasome/Il-1β Axis Via Targeting Smad7 and Spry1, Antioxid Redox Signal, 27, 1, 10.1089/ars.2016.6669

Cai, 2016, Angiotensin-(1-7) Improves Liver Fibrosis by Regulating the Nlrp3 Inflammasome Via Redox Balance Modulation, Antioxid Redox Signal, 24, 795, 10.1089/ars.2015.6498

Wang, 2020, Calcipotriol Inhibits Nlrp3 Signal Through Yap1 Activation to Alleviate Cholestatic Liver Injury and Fibrosis, Front Pharmacol, 11, 10.3389/fphar.2020.00200

Shan, 2020, Purine Signaling Regulating Hscs Inflammatory Cytokines Secretion, Activation, and Proliferation Plays a Critical Role in Alcoholic Liver Disease, Mol Cell Biochem, 466, 91, 10.1007/s11010-020-03691-0

Sasaki, 2017, Hepatitis C Virus-Induced Ccl5 Secretion From Macrophages Activates Hepatic Stellate Cells, Hepatology, 66, 10.1002/hep.29170

Arriola Benitez, 2019, Brucella Abortus Infection Elicited Hepatic Stellate Cell-Mediated Fibrosis Through Inflammasome-Dependent Il-1β Production, Front Immunol, 10, 10.3389/fimmu.2019.03036

Lu, 2017, Nlrp3 Inflammasome Activation Results in Liver Inflammation and Fibrosis in Mice Infected With Schistosoma Japonicum in a Syk-Dependent Manner, Sci Rep, 7, 8120, 10.1038/s41598-017-08689-1

Li, 2020, Role of Aldosterone in the Activation of Primary Mice Hepatic Stellate Cell and Liver Fibrosis Via Nlrp3 Inflammasome, J Gastroenterol Hepatol, 35, 10.1111/jgh.14961

Ridker, 2017, Antiinflammatory Therapy With Canakinumab for Atherosclerotic Disease, N Engl J Med, 377, 10.1056/NEJMoa1707914

Blasetti Fantauzzi, 2017, Deficiency of the Purinergic Receptor 2x(7) Attenuates Nonalcoholic Steatohepatitis Induced by High-Fat Diet: Possible Role of the Nlrp3 Inflammasome, Oxid Med Cell Longev, 2017, 10.1155/2017/8962458

Li, 2019, Activated Nk Cells Kill Hepatic Stellate Cells Via P38/Pi3k Signaling in a Trail-Involved Degranulation Manner, J Leukoc Biol, 105, 695, 10.1002/jlb.2a0118-031rr

Nilsson, 2020, Nkt Cells Promote Both Type 1 and Type 2 Inflammatory Responses in a Mouse Model of Liver Fibrosis, Sci Rep, 10, 21778, 10.1038/s41598-020-78688-2

Nichols, 2017, Naip/Nlrc4 Inflammasome Activation in Mrp8(+) Cells Is Sufficient to Cause Systemic Inflammatory Disease, Nat Commun, 8, 2209, 10.1038/s41467-017-02266-w

Szabo, 2017, Clinical Trial Design for Alcoholic Hepatitis, Semin Liver Dis, 37, 10.1055/s-0037-1608788

Larsen, 2007, Interleukin-1-Receptor Antagonist in Type 2 Diabetes Mellitus, N Engl J Med, 356, 10.1056/NEJMoa065213

Petrasek, 2012, Il-1 Receptor Antagonist Ameliorates Inflammasome-Dependent Alcoholic Steatohepatitis in Mice, J Clin Invest, 122, 10.1172/jci60777

Morrison, 2016, Intervention With a Caspase-1 Inhibitor Reduces Obesity-Associated Hyperinsulinemia, Non-Alcoholic Steatohepatitis and Hepatic Fibrosis in Ldlr-/-, Leiden Mice Int J Obes (Lond), 40, 10.1038/ijo.2016.74

Witek, 2009, Pan-Caspase Inhibitor Vx-166 Reduces Fibrosis in an Animal Model of Nonalcoholic Steatohepatitis, Hepatology, 50, 10.1002/hep.23167

Barreyro, 2015, The Pan-Caspase Inhibitor Emricasan (Idn-6556) Decreases Liver Injury and Fibrosis in a Murine Model of Non-Alcoholic Steatohepatitis, Liver Int, 35, 10.1111/liv.12570

Mridha, 2017, Nlrp3 Inflammasome Blockade Reduces Liver Inflammation and Fibrosis in Experimental Nash in Mice, J Hepatol, 66, 10.1016/j.jhep.2017.01.022

Baeza-Raja, 2020, Pharmacological Inhibition of P2rx7 Ameliorates Liver Injury by Reducing Inflammation and Fibrosis, PloS One, 15, 10.1371/journal.pone.0234038

Gabay, 2010, Il-1 Pathways in Inflammation and Human Diseases, Nat Rev Rheumatol, 6, 10.1038/nrrheum.2010.4

Yan, 2021, Mcc950 Ameliorates Acute Liver Injury Through Modulating Macrophage Polarization and Myeloid-Derived Suppressor Cells Function, Front Med (Lausanne), 8, 10.3389/fmed.2021.752223

von Moltke, 2012, Rapid Induction of Inflammatory Lipid Mediators by the Inflammasome in Vivo, Nature, 490, 10.1038/nature11351

Ramachandran, 2012, Differential Ly-6c Expression Identifies the Recruited Macrophage Phenotype, Which Orchestrates the Regression of Murine Liver Fibrosis, Proc Natl Acad Sci U S A, 109, 10.1073/pnas.1119964109

Weng, 2007, Ifn-Gamma Abrogates Profibrogenic Tgf-Beta Signaling in Liver by Targeting Expression of Inhibitory and Receptor Smads, J Hepatol, 46, 295, 10.1016/j.jhep.2006.09.014

Li, 2016, Intrahepatic Nk Cells Function Suppressed in Advanced Liver Fibrosis, Eur J Clin Invest, 46, 10.1111/eci.12669

Liang, 2018, Inhibition of Il-18 Reduces Renal Fibrosis After Ischemia-Reperfusion, BioMed Pharmacother, 106, 10.1016/j.biopha.2018.07.031

Prior, 2019, Liver Organoids: From Basic Research to Therapeutic Applications, Gut, 68, 10.1136/gutjnl-2019-319256

Sarmah, 2022, Sirtuin-1 - Mediated Nf-κb Pathway Modulation to Mitigate Inflammasome Signaling and Cellular Apoptosis Is One of the Neuroprotective Effects of Intra-Arterial Mesenchymal Stem Cell Therapy Following Ischemic Stroke, Stem Cell Rev Rep, 18, 10.1007/s12015-021-10315-7